Helen of Troy Limited
NASDAQ:HELEHousehold & Personal Products
+$0.47 today
- Market cap
- $866.62M
- Beta
- 1.33
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$39.08
Volume 0.29M
Average 0.65M
HELE Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Helen of Troy LimitedNASDAQ: HELE
Research & Development · Q4 FY2026 · quarter ended Feb 2026
Research & development remains negative
Q4 FY2026 research & development was $0, compared with $53.9M a year earlier. Trailing-twelve-month research & development was $0. Over 3 fiscal years it compounded at +4.1% a year.
Context
- Research & development amounted to 3.0% of revenue in FY2026, up 0.2 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 54M USD
- Year-over-year change
- +0.2%
- 4-year CAGR
- +0.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-02-28 | 54M | +0.2% |
| FY2025 | 2025-02-28 | 53.9M | -4.6% |
| FY2024 | 2024-02-28 | 56.5M | +18.2% |
| FY2023 | 2023-02-28 | 47.8M | -11.5% |
| FY2022 | 2022-02-28 | 54M | — |
Research & Development vs competitors
How HELE compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -100.0% is the 3rd highest of 4, against a peer median of -0.8%.
- Research & development amounts to 0.0% of revenue for HELE, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $180M USD | — | — | 1.2% | |
| LTM Sep 2026 | $117M USD | -0.8% | -5.6% | 1.6% | |
| LTM Mar 2026 | $58.5M USD | -0.3% | +1.2% | 2.8% | |
| LTM Feb 2026 | $0 USD | -100.0% | +4.1% | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| FY2025 | €0 EUR | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding HELE) | — | -0.8% | -2.2% | 0.0% | |
Competitors are the stored peer set for HELE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Feb 2022 | FY2023 Feb 2023 | FY2024 Feb 2024 | FY2025 Feb 2025 | FY2026 Feb 2026 |
|---|---|---|---|---|---|
| Revenue | 2.22B | 2.07B | 2.01B | 1.91B | 1.79B |
| Cost of Revenue | 1.27B | 1.17B | 1.06B | 993.26M | 970.6M |
| Gross Profit | 953.19M | 899.35M | 948.66M | 914.41M | 815.69M |
| Gross Margin | 42.9% | 43.4% | 47.3% | 47.9% | 45.7% |
| Research & Development | 54M | 47.8M | 56.5M | 53.9M | 54M |
| Selling, General & Admin | 611.03M | 595.9M | 621.74M | 622.65M | 708.91M |
| Operating Expenses | 680.64M | 687.56M | 688.07M | 771.66M | 708.91M |
| Depreciation & Amortization | 35.83M | 44.68M | 51.5M | 55.05M | 53.3M |
| EBITDA | 310.88M | 286.94M | 301.32M | 268.61M | (727.8M) |
| EBITDA Margin | 14.0% | 13.8% | 15.0% | 14.1% | -40.7% |
| Operating Income | 272.55M | 211.79M | 260.59M | 142.75M | 106.79M |
| Operating Margin | 12.3% | 10.2% | 13.0% | 7.5% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 12.84M | 40.75M | 53.07M | 51.92M | 57.74M |
| Other Income / Expenses | (12.58M) | (40.5M) | (51.55M) | (51.08M) | (945.62M) |
| Income Before Tax | 259.97M | 171.29M | 209.04M | 91.66M | (838.84M) |
| Pre-Tax Margin | 11.7% | 8.3% | 10.4% | 4.8% | -47.0% |
| Income Tax Expense | 36.2M | 28.02M | 40.45M | (32.09M) | 60.14M |
| Net Income | 223.76M | 143.27M | 168.59M | 123.75M | (898.98M) |
| Net Margin | 10.1% | 6.9% | 8.4% | 6.5% | -50.3% |
| EPS (Basic) | 9.27 | 5.98 | 7.06 | 5.38 | (39.08) |
| EPS (Diluted) | 9.17 | 5.95 | 7.03 | 5.37 | (39.08) |
| Weighted Avg Shares | 24.4M | 24.08M | 23.98M | 23.04M | 23M |
| Weighted Avg Shares (Diluted) | 24.41M | 24.09M | 23.97M | 23.07M | 23M |
Helen of Troy Limited
NASDAQ:HELE
Intrinsic Alpha fair value
Locked
Current Price
$37.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.